Intracerebral Hemorrhage as an Axonal Tract Injury Disorder with Inflammatory Reactions

Biol Pharm Bull. 2017;40(5):564-568. doi: 10.1248/bpb.b16-01013.

Abstract

Intracerebral hemorrhage (ICH) is a neurological disorder frequently accompanied by severe dysfunction. Critical pathogenic events leading to poor prognosis should be identified for the development of novel effective therapies for ICH. Here we focus on the injury of the axonal tract, particularly of the internal capsule, with reference to its contribution to ICH pathology and potential therapeutic interventions in addition to its cellular mechanisms. Studies on human ICH patients and rodent models of ICH suggest that invasion of hematoma into the internal capsule greatly worsens the severity of post-ICH symptoms. A blood-derived protease thrombin may play an important role in the acute phase of axonal tract injury in the internal capsule that includes compromised axonal transport and fragmentation of axonal structures. Several agents such as clioquinol, melatonin and Am80 (a retinoic acid receptor agonist) have been shown to produce therapeutic effects on rodent models of ICH associated with injury of the internal capsule. In the course of examinations on the effect of Am80, we obtained evidence for the involvement of CXCL2, a neutrophil chemotactic factor, in the pathogenesis of ICH. Accordingly, we also refer to the potential roles of infiltrating neutrophils and inflammatory responses in axonal tract injury and resultant neurological dysfunction in ICH.

Keywords: axonal degeneration; chemokine; hemorrhagic stroke; motor deficit; neutrophil.

Publication types

  • Review

MeSH terms

  • Animals
  • Axons / pathology*
  • Cerebral Hemorrhage / pathology*
  • Encephalitis / pathology*
  • Humans
  • Mice
  • Rats
  • Stroke / pathology